Elligo Health Research Partners with Austin Cancer Center

Applied Clinical Trials

Elligo Health Research, a healthcare-enabling research organization, announced its partnership with Austin Cancer Center (ACC), an independent oncology group in central Texas. The partnership expands Elligo’s Research Ready network to include its first oncology practice, broadening Elligo’s therapeutic specialization and allowing ACC’s oncologists to offer research as a care option. ACC is currently enrolling patients for studies in breast cancer.

“Partnering with Elligo allows us to bring cutting-edge capabilities to our patients,” said Blayne Rush, MBA, ACC’s CEO. “We’re excited they can remain under our care while benefiting from the innovative treatments available through participation in clinical studies.”

“Bringing the Research Ready network to cancer patients in this area is a milestone achievement in our promise to preserve the trusted patient and physician relationship and unite the best clinical experts with the best research infrastructure,” said John Potthoff, PhD, Elligo’s CEO.

Learn more at elligodirect.com